The FSGS Clinical Trial is a multi-center, prospective, controlled, open label randomized
trial designed to determine if treatment with mycophenolate mofetil (MMF) in conjunction with
pulse steroids is superior to treatment with Cyclosporine-A (CSA) in inducing remission from
proteinuria over 12 months.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)